
Join to view full profile
2346 ashleigh driveYork, PA 17403
Phone+1 717-741-1414
Fax+1 717-741-4774
Dr. Wang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Virginia Medical CenterFellowship, Gastroenterology, 2001 - 2004
Prisma Health/University of South Carolina SOM Columbia (Columbia)Residency, Internal Medicine, 1997 - 2000
Chongqing Medical UniversityClass of 1983
Certifications & Licensure
SC State Medical License 2000 - 2027
PA State Medical License 2004 - 2026
VA State Medical License 2004 - 2026
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification gGastro, gMed, Inc., 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification gGastro, gMed, Inc., 2011, 2013-2014, 2016-2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 39 citationsThe XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma.Yijun Lu, Qikai Sun, Qifei Guan, Zechuan Zhang, Qifeng He
Journal of Hepatology. 2023-11-01 - 61 citationsAdvancing cell-based cancer immunotherapy through stem cell engineering.Yan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, Miao Li, Pin Wang
Cell Stem Cell. 2023-05-04 - 17 citationsDiagnostic value of endoscopic ultrasound-guided fine needle aspiration with rapid on-site evaluation performed by endoscopists in solid pancreatic lesions: A prospect...Song Zhang, Muhan Ni, Pin Wang, Jinyu Zheng, Qi Sun
Journal of Gastroenterology and Hepatology. 2022-10-01
Press Mentions
Vivacta Bio Announces Promising First-in-Human Results for GT801, an in Vivo CAR-T Therapy, in Non-Hodgkin's Lymphoma at the 2025 ASH Annual MeetingDecember 6th, 2025
Interferon-Inducible Cytoplasmic lncLrrc55-AS Promotes Antiviral Innate Responses by Strengthening IRF3 PhosphorylationJune 18th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









